Portfolio company Resilience in the news: “Resilience Establishes Multi-Product Development and Manufacturing Collaboration with Takeda’s Plasma-Derived Therapies Business Unit”

The greatest return is serving those who put their lives on the line: our nation’s high-risk public servants.

Linkedin-in

Risk & Return 2021. All rights reserved.